SaxoCell Conference on Cell and Gene Therapy

Explore the Future of Cell and Gene Therapy Development

hVIVO will be attending the SaxoCell Conference, a focused forum bringing together leaders from academia, biotech, and industry to explore the latest advances in cell and gene therapy. With a strong emphasis on innovation, translation, and collaboration, the event provides a valuable platform to connect across the development lifecycle.

Our team will be on-site to discuss how our early-phase clinical expertise, infectious disease capabilities, and integrated consultancy services can support the progression of advanced therapies from concept through to clinical delivery. We welcome the opportunity to connect with partners looking to accelerate development in complex and emerging therapeutic areas.

Conference Highlights

• Dedicated sessions on cell and gene therapy in oncology and autoimmune diseases

   

• Focus on emerging delivery technologies and genetic engineering innovations

   

• Pitch sessions showcasing early-stage companies and R&D teams

   

• Panel discussions addressing key development challenges, including translation to market

   

• Cross-sector audience of 150+ participants from academia, clinics, and industry

   

• Strong networking environment designed to foster collaboration and partnerships